Document is current

Discontinuation of tyrosine kinase therapy in CML

Crossref DOI link: https://doi.org/10.1007/s00277-015-2320-4

Published Online: 2015-03-27

Published Print: 2015-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy